HBM Healthcare Investments AG provided earnings guidance for the first nine months ended December 31, 2021. For the period, the company expected a net profit of approximately CHF 275 million for this period (previous year net profit of CHF 644.6 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205 CHF | +0.49% |
|
-1.20% | +12.27% |
05-28 | HBM Healthcare Flags NAV Boost from Yellow Jersey-Johnson & Johnson Deal | MT |
05-23 | HBM Healthcare Investments' Portfolio Company to Buy Laboratorios Biopas Group | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.27% | 1.57B | |
+22.68% | 3.27B | |
+12.50% | 1.76B | |
-11.54% | 1.22B | |
+31.84% | 869M | |
+7.16% | 649M | |
+52.03% | 640M | |
-4.17% | 502M | |
+21.74% | 443M | |
+32.76% | 325M |
- Stock Market
- Equities
- HBMN Stock
- News HBM Healthcare Investments AG
- HBM Healthcare Investments AG Provides Earnings Guidance for the First Nine Months Ended December 31, 2021